MetLife Investment Management LLC Sells 952 Shares of Ryan Specialty Holdings Inc. $RYAN

30 Aug 2025, 04:28 by Jessica Moore · The Cerbat Gem

MetLife Investment Management LLC lessened its holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,461 shares of the company’s stock after selling 952 shares during the quarter. MetLife Investment Management LLC’s holdings in Ryan Specialty were worth $4,688,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of RYAN. Mariner LLC grew its position in Ryan Specialty by 3.4% in the 4th quarter. Mariner LLC now owns 5,278 shares of the company’s stock valued at $339,000 after acquiring an additional 172 shares during the last quarter. Hsbc Holdings PLC grew its position in Ryan Specialty by 16.4% in the 4th quarter. Hsbc Holdings PLC now owns 3,654 shares of the company’s stock valued at $234,000 after acquiring an additional 514 shares during the last quarter. Susquehanna International Group LLP grew its position in Ryan Specialty by 31.1% in the 4th quarter. Susquehanna International Group LLP now owns 39,593 shares of the company’s stock valued at $2,540,000 after acquiring an additional 9,393 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Ryan Specialty by 2.5% in the 4th quarter. The Manufacturers Life Insurance Company now owns 85,528 shares of the company’s stock valued at $5,487,000 after acquiring an additional 2,119 shares during the last quarter. Finally, Northern Trust Corp grew its position in Ryan Specialty by 20.5% in the 4th quarter. Northern Trust Corp now owns 891,112 shares of the company’s stock valued at $57,174,000 after acquiring an additional 151,391 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Down 0.3%

Shares of NYSE RYAN opened at $56.47 on Friday. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a market capitalization of $14.89 billion, a P/E ratio of 161.36, a price-to-earnings-growth ratio of 1.58 and a beta of 0.64. Ryan Specialty Holdings Inc. has a 1-year low of $55.77 and a 1-year high of $77.16. The business has a fifty day moving average price of $62.69 and a 200 day moving average price of $67.09.

Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.66. The firm had revenue of $855.17 million during the quarter, compared to analysts’ expectations of $837.52 million. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The firm’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 EPS. Equities research analysts expect that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Tuesday, August 12th. Ryan Specialty’s dividend payout ratio is 137.14%.

Insiders Place Their Bets

In related news, EVP Mark Stephen Katz sold 14,377 shares of the company’s stock in a transaction on Friday, June 13th. The stock was sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president directly owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director David P. Bolger sold 5,000 shares of the stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director owned 71,467 shares of the company’s stock, valued at approximately $5,059,863.60. This trade represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on RYAN. Wall Street Zen raised Ryan Specialty from a “sell” rating to a “hold” rating in a research report on Sunday, August 3rd. UBS Group lowered their target price on Ryan Specialty from $84.00 to $80.00 and set a “buy” rating for the company in a report on Monday, August 4th. Cantor Fitzgerald upgraded Ryan Specialty to a “hold” rating in a report on Wednesday, August 13th. Citigroup started coverage on Ryan Specialty in a report on Wednesday, August 13th. They issued a “buy” rating and a $74.00 target price for the company. Finally, Wells Fargo & Company lowered their target price on Ryan Specialty from $63.00 to $60.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $74.83.

View Our Latest Stock Analysis on RYAN

Ryan Specialty Profile

(Free Report)